Clinical Trials Using CSF1R Inhibitor DCC-3014

Clinical trials are research studies that involve people. The clinical trials on this list are studying CSF1R Inhibitor DCC-3014. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Study of DCC-3014 in Patients With Advanced Tumors

    This is a multicenter, open-label Phase 1 study of DCC-3014 in patients with advanced solid tumors including but not limited to prostate, breast, gastric, ovarian, and non-small cell lung cancer as well as tumor types with high macrophage content or high expression of CSF-1 such as diffuse-type tenosynovial giant cell tumor. There will be an Escalation Phase and an Expansion Phase in this study
    Location: 2 locations